(Q51624978)

English

Long-term comparison of oral hypoglycemic agents in diabetic retinopathy. Gliclazide vs. other sulfonylureas.

scientific article published in July 1988

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3416710

Long-term comparison of oral hypoglycemic agents in diabetic retinopathy. Gliclazide vs. other sulfonylureas. (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3416710

1 reference

based on heuristic

inferred from title

author name string

Y Akanuma

1

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3416710

K Kosaka

2

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3416710

Y Kanazawa

3

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3416710

M Kasuga

4

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3416710

M Fukuda

5

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3416710

S Aoki

6

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3416710

publication date

1 July 1988

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3416710

Diabetes Research and Clinical Practice

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3416710

5

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3416710

2

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3416710

81-90

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3416710

Effects of gliclazide, a new antidiabetic agent, on the platelet release reaction, role of adenylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2888%2980046-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Preventive effect of gliclazide on experimental atherosclerosis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2888%2980046-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of gliclazide on prostaglandin I2 formation in normal and streptozotocin-induced diabetic animals

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2888%2980046-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical study on diabetes mellitus (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2888%2980046-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8227(88)80046-9

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3416710

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/3416710

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51624978&oldid=1569862836"